Concord Drugs has informed the exchange that at the Board meeting held on 01.06.2022 at the registered office of the Company, the following were considered and approved by the Board; Appointment of K. Sumeela as additional director of the Company in Independent category with effect from 01.06.2022 and Resignation of P. Chandrakala as Independent Director of the Company with effect from 01.06.2022.
The above information is a part of company’s filings submitted to BSE.